AZEEM AHMAD

Dr. AZEEM AHMAD

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 September 2023 in Journal of Herbal Medicine
Verified
Journal Article
Open access
KCKULDEEP CHOUDHARY
KULDEEP CHOUDHARY
MGM. Gundeti
M. Gundeti
PDP. Dave
P. Dave
SGS. Goel
S. Goel
AAAZEEM AHMAD
AZEEM AHMAD
RAR. Acharya
R. Acharya

28 October 2025 in Journal of Complementary and Integrative Medicine
Verified
Journal Article
Open access
DJDanish Javed
Danish Javed
ARAmit Kumar Rai
Amit Kumar Rai
ATAthulya Th
Athulya Th
SMSai Thejesh Molakapuri
Sai Thejesh Molakapuri
AAAZEEM AHMAD
AZEEM AHMAD
GDGaurav Dhingra
Gaurav Dhingra
Introduction: While conventional medicine (CM) has improved outcomes for individuals with sickle cell disease (SCD), issues with accessibility, affordability, and potential adverse effects limit its widespread use. As a result, many patients and caregivers turn to traditional medicine (TM) as an alternative approach to managing SCD. This scoping review aims to systematically evaluate the efficacy, safety, and potential mechanisms of action of TM in SCD, while exploring its integration with CM. Content: A systematic search was conducted in PubMed, Scopus, Web of Science, Cochrane Library, EMBASE, and AYUSH Research Portal. Clinical trials, observational studies, in vitro and in vivo studies, and ethnopharmacological surveys investigating TM interventions in SCD were included. Summary and outlook: Of the 27 selected studies, 11 were in vitro , four in vivo , six clinical trials, and six qualitative surveys. Several medicinal plants demonstrated promising anti-sickling, antioxidant, anti-inflammatory, and immunomodulatory properties. Formulations such as Niprisan ® , Ciklavit ® , and T-AYU-HM™ Premium showed potential in reducing vaso-occlusive crises and improving hematological parameters. However, limitations include variability in herbal formulations, lack of standardization, and inadequate RCTs. While preliminary findings are promising, further well-designed RCTs are needed to establish the efficacy of TM in SCD. Integrating evidence-based TM with CM options could provide a holistic and patient-centered strategy for SCD.

6 January 2025 in Journal of Evidence-Based Integrative Medicine
Verified
Journal Article
Open access
AMAkashlal M.
Akashlal M.
PNPratibha P Nair
Pratibha P Nair
DNDevi R Nair
Devi R Nair
AAAZEEM AHMAD
AZEEM AHMAD
BCB Chandrasekhararao
B Chandrasekhararao
RARabinarayan Acharya
Rabinarayan Acharya
The study's objective is to conduct a comprehensive systematic review for assessing the safety and efficacy of Ayurvedic interventions in managing hemiplegia/Pakshaghata. The study involved a search across multiple online databases and online clinical trial registries. Additionally, major Ayurveda postgraduate institutes were contacted to acquire unpublished trial data related to hemiplegia/Pakshaghata. The review covered articles published until July 2023. Two reviewers independently performed data extraction and risk of bias assessment. The risk of bias assessment utilised the RoB 2 tool for randomised trials and the ROBINS-I tool for non-randomised trials. The screening process identified 28 articles from online databases and two dissertations from online repositories. However, practical challenges prevented access to grey literature from Ayurveda institutes. The 30 studies selected for this review, comprises nine randomised controlled trials (RCTs), eight non-randomised comparative trials, and thirteen pre-post studies. Quantitative analysis was unfeasible due to inadequate studies, leading to a qualitative analysis. All studies, except one, exhibited substantial bias upon risk of bias assessment. Moreover, most studies demonstrated methodological weaknesses attributed to a lack of masking, improper sampling techniques, non-validated outcome measurement tools, inadequate follow-up procedures, and confounding factors. The trials frequently did not document safety parameters, adverse events (AE), and adverse drug reactions (ADR). Current review could not definitively establish the efficacy and safety of Ayurvedic interventions in hemiplegia/Pakshaghata. Hence, the authors strongly advocate for good quality research incorporating proper methodology.

30 June 2016 in Journal of Ayurveda and Integrated Medical Sciences
Verified
Journal Article
Open access
PDF file
AAAZEEM AHMAD
AZEEM AHMAD
SSSingh Sarika
Singh Sarika
Man, the superior most of all the species is always remaining in search of one prime goal; The perfect health. From Vedic era to space age, all the researches have been directed by the eminent scholars to achieve the same. Ancient Acharyas and their counterparts in this era tried and still trying their best to beep the man young and virile. Management of chronic non-healing ulcer has always been a difficult proposition in the evolution of medical practices. Throughout the ages, man was seeking better management of wound and ulcers. The current treatment used to treat non-healing ulcer is by antibiotics, anti-inflammatory drugs, wound debridement, irrigation, hyperbaric oxygenation, vacuum assisted closure, maggot therapy etc. Many of such technique are much expensive and are not successful in many cases. Hence, a technique from Ayurvedic classics Dhoopana which is less expensive was selected for the study.

1 January 2019 in Journal of Research in Ayurvedic Sciences
Verified
Journal Article
Closed access
SGSumeet Goel
Sumeet Goel
SKShruti Khanduri
Shruti Khanduri
AAAZEEM AHMAD
AZEEM AHMAD
AKArvind Kumar
Arvind Kumar
RSRajeshwari Singh
Rajeshwari Singh
Narayanam SrikanthNarayanam Srikanth
Narayanam Srikanth
Introduction: Rheumatoid arthritis (RA) has been treated in Ayurveda, and substantial work has been done in studying the role of Ayurveda interventions in its management. A systematic review is planned to investigate the safety and efficacy of Ayurveda interventions for RA through analyzing published clinical research work. Materials and methods: This study is intended to systematically review the existing published clinical work including randomized controlled trials (RCTs), controlled clinical trials, parallel-group trials, and single-group clinical studies for Ayurveda interventions for RA. Electronic search of the following databases will be performed: PubMed, AYUSH research portal, digital helpline for Ayurveda research articles (DHARA), Google Scholar, the Cochrane Library (the Cochrane Database of systematic reviews, the Cochrane Central Register of Controlled Trials (CENTRAL), and the Cochrane Methodology Register), Ayurveda college/Universities websites, databases for dissertation works without any restriction of publication year. Hand search and snowballing of studies will also be performed to fetch complete available literature. The selection of the studies, data abstraction, and validations will be performed independently by two teams of researchers. Conclusion will be derived with consensus of complete review team. Study selection will follow the preferred reporting items for systematic reviews and meta-analyses (PRISMA) guidelines, and study quality will be assessed by CONSORT checklist for RCTs, Transparent Reporting of Evaluations with Nonrandomized Designs (TREND) checklist for nonrandomized controlled trial (NRCTs), and CONSORT extension for Pilot and feasibility studies for pilot studies. Risk of bias assessment will be performed with the help of Cochrane RoB2 tool for RCTs and Risk of Bias in Non-randomized Studies of Interventions (ROBINS-I) tool for NRCTs. If sufficient and appropriate data are available, a meta-analysis will be conducted. Subgroup and sensitivity analyses will be performed if found to be necessary and feasible. Ethics and dissemination: Formal ethical approval is not required as primary data will not be collected. The results will be disseminated through a peer-reviewed publication. The review will be updated to inform and guide healthcare practice and policy. Trial Registration Number: International Prospective Register for Systematic Reviews (PROSPERO) number 2019 CRD42019133722.

20 January 2026 in Systematic Reviews
Verified
Journal Article
Open access
PDF file
AAAZEEM AHMAD
AZEEM AHMAD
MGManohar S. Gundeti
Manohar S. Gundeti
MRMeena R
Meena R
EWEugene Wilson
Eugene Wilson
MIMalik Itrat
Malik Itrat
GRGalib R
Galib R
The novel coronavirus (COVID-19), caused by SARS-CoV-2, was first reported in Wuhan, China, in December 2019. Its rapid spread, high mutation rate, and cha